Jonathan T. Pham

Internal Medicine

1500 Red River St
Austin, TX 78701

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Vedolizumab as a Second Line Biologic for Cronkhite Canada Syndrome and an Approach Toward Disease Monitoring.

Vedolizumab as a Second Line Biologic for Cronkhite Canada Syndrome and an Approach Toward Disease Monitoring.

Journal: ACG case reports journal

Published: August 18, 2025

Showing 1-1 of 1

Last Updated: 09/26/2026